Reducing perioperative myocardial infarction with anesthetic drugs and techniques

Current Drug Targets

Volumn 10, Issue 9, 2009, Pages 858-862

  Landoni, G ^a   Zambon, M ^a   Zangrillo, A ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Anaesthesia; Levosimendan; Mortality; Myocardial infarction; Outcome; Surgery; Volatile anaesthetics

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANESTHETIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DESFLURANE; DEXMEDETOMIDINE; ESMOLOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INHALATION ANESTHETIC AGENT; INOTROPIC AGENT; INTRAVENOUS ANESTHETIC AGENT; LEVOSIMENDAN; METOPROLOL; MIVAZEROL; PLACEBO; SEVOFLURANE;

ABDOMINAL SURGERY; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG CHOICE; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; EPIDURAL ANESTHESIA; EVIDENCE BASED MEDICINE; HEART DISEASE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART SURGERY; HIGH RISK PATIENT; HUMAN; MEDICAL LITERATURE; MORTALITY; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; REVIEW; RISK BENEFIT ANALYSIS; SURGICAL TECHNIQUE; UNSTABLE ANGINA PECTORIS;

ANESTHETICS; HUMANS; HYDRAZONES; MYOCARDIAL INFARCTION; PERIOPERATIVE CARE; PYRIDAZINES; VASODILATOR AGENTS;

EID: 70450189802     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945009789108837     Document Type: Review

References (37)

1. LeLorier J, Grégoire G, Benhaddad A, Lapierre J, Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997; 337: 536-42.
2. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, et al. ACC/AHA 2007 Guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary. J Am Coll Cardiol 2007; 50: 1707-32.
3. Landoni G. Epidural anesthesia and analgesia in cardiac surgery. Minerva Anestesiol 2008; 74: 617-8.
4. Landoni G, Biondi-Zoccai G, Zangrillo A, Bignami E, D'Avolio S, Marchetti C, et al. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 2007; 21: 502-11.
5. Seccareccia F, Perucci CA, D'Errigo P, Arcà M, Fusco D, Rosato S, et al. The Italian CABG outcome study: short-term outcomes in patients with coronary artery bypass graft surgery. Eur J Cardiothorac Surg 2006; 29: 56-62.
6. Bignami E, Biondi-Zoccai G, Landoni G, Testa V, Sheiban I, Giunta F, et al. Volatile anesthetics reduce mortality in cardiac surgery. J Cardiothorac Vasc Anesth 2009 [Epub ahead of print] PMID: 19303327.
7. Tritapepe L, Landoni G, Guarracino F, Pompei F, Crivellari M, Maselli D, et al. Cardiac protection by volatile anaesthetics: a multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Eur J Anaesthesiol 2007; 24: 323-31.
8. Guarracino F, Landoni G, Tritapepe L, Pompei F, Leoni A, Aletti G. Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study. J Cardiothorac Vasc Anesth 2006; 20: 477-83.
9. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, Van Reeth V, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004; 101: 299-310.
10. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-36.
11. Landoni G, Fochi O, Zangrillo A. Cardioprotection by volatile anesthetics in noncardiac surgery? No, not yet at least. J Am Coll Cardiol 2008; 51: 1321.
12. Landoni G, Zangrillo A, Fochi O, Maj G, Scandroglio AM, Morelli A, et al. Cardiac protection with volatile anesthetics in stenting procedures. J Cardiothorac Vasc Anesth 2008; 22: 543-7.
13. Landoni G, Mizzi A, Biondi Zoccai G, Bruno G, Bignami E, Corno L et al. Reducing mortality in cardiac surgery with levosimendan: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth 2009 (in press).
14. Zangrillo A, Biondi-Zoccai G, Mizzi A, Bruno G, Bignami E, Gerli C, et al. Levosimendan reduces cardiac troponin release after cardiac surgery: a meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth 2009 [Epub ahead of print] PMID: 19217315.
15. Toller WG, Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anesthesiology 2006; 104: 556-69.
16. Lilleberg J, Nieminen MS, Akkila J, Heikkilä L, Kuitunen A, Lehtonen L, et al. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 1998; 19: 660-8.
17. POISE Study Group, Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008; 371: 1839-47.
18. Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli FH. Perioperative beta blockers in patients having noncardiac surgery: a meta-analysis. Lancet 2008; 372: 1962-76.
19. Fita G, Gomar C, Rovira I. Esmolol in anesthesiology: pharmacology and indications. Rev Esp Anestesiol Reanim 1999; 46: 404-14.
20. Zangrillo A, Turi S, Crescenzi G, Oriani A, Distaso F, Monaco F, et al. Esmolol reduces perioperative ischemia in cardiac surgery: a meta-analysis of randomized controlled Studies. J Cardiothorac Vasc Anesth 2009 [Epub ahead of print] PMID: 19297196.
21. Landoni G, Turi S, Biondi Zoccai G, Bignami E, Testa V, Belloni I et al. Esmolol reduces perioperative ischemia in non-cardiac surgery. A meta-analysis of randomized controlled studies. J Cardiothorc Vasc Anesth 2009 (in press).
22. Nishimori M, Ballantyne JC, Low JH. Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery. Cochrane Database Syst Rev 2006; 3: CD005059.
23. Pöpping DM, Elia N, Marret E, Remy C, Tramèr MR. Protective effects of epidural analgesia on pulmonary complications after abdominal and thoracic surgery: a meta-analysis. Arch Surg 2008; 143: 990-9.
24. Wijeysundera DN, Beattie WS, Austin PC, Hux JE, Laupacis A. Epidural anaesthesia and survival after intermediate-to-high risk non-cardiac surgery: a population-based cohort study. Lancet 2008; 372: 562-9.
25. Liu SS, Block BM, Wu CL. Effects of perioperative central neuraxial analgesia on outcome after coronary artery bypass surgery: a meta-analysis. Anesthesiology 2004; 101: 153-61.
26. Crescenzi G, Landoni G, Monaco F, Bignami E, De Luca M, Frau G, et al. Epidural anesthesia in elderly patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2009 [Epub ahead of print] PMID: 19376734.
27. Liu S, Carpenter RL, Neal JM. Epidural anesthesia and analgesia: their role in postoperative outcome. Anesthesiology 1995; 82: 1474-506.
28. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990; 72: 153-84.
29. Wijeysundera DN, Beattie WS. Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: a metaanalysis. Anesth Analg 2003; 97: 634-41.
30. Wijeysundera DN, Beattie WS, Rao V, Karski J. Calcium antagonists reduce cardiovascular complications after cardiac surgery: a meta-analysis. J Am Coll Cardiol 2003; 41: 1496-505. Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 12742289? ordinalpos=7&itool=EntrezSystem2.PEntrez.Pubmed. Pubmed- ResultsPanel.Pubmed-DefaultReportPanel.Pubmed-RVDocSum
31. Wijeysundera DN, Naik JS, Beattie WS. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med 2003; 114: 742-52.
32. Hindler K, Shaw AD, Samuels J, Fulton S, Collard CD, Riedel B. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 2006; 105: 1260-72.
33. Durazzo AE, Machado FS, Ikeoka DT, De Bernoche C, Monachini MC, Puech-Leão P, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 2004; 39: 967-75.
34. Landoni G, Biondi-Zoccai GG, Marino G, Bove T, Fochi O, Maj G, et al. Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a metaanalysis. J Cardiothorac Vasc Anesth 2008; 22: 27-33.
35. Landoni G, Biondi-Zoccai GG, Tumlin JA, Bove T, De Luca M, Calabrò MG, et al. Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Am J Kidney Dis 2007; 49: 56-68.
36. Testa L, Van Gaal WJ, Bhindi R, Biondi-Zoccai GG, Abbate A, Agostoni P, et al. Pexelizumab in ischemic heart disease: a systematic review and meta-analysis on 15,196 patients. J Thorac Cardiovasc Surg 2008; 136: 884-93.
37. Crescenzi G, Pappalardo F, Rosica C, Gonfalini M, Landoni G, Zangrillo A. Tricks and pitfalls regarding the hemodynamics of patients undergoing non-transplantation surgery for heart failure. Minerva Anestesiol 2008; 74: 715-25.